Literature DB >> 25126264

An overview of cholesterol management.

Robyn A Burns Schaiff1, Richard M Moe2, Daniel W Krichbaum3.   

Abstract

Cardiovascular disease is the leading cause of death worldwide. Elevated cholesterol (hypercholesterolemia) and abnormal lipid profiles (dyslipidemia) are important risk factors for the development of cardiovascular disease. This article discusses the role of cholesterol in the body and the relationship between different cholesterol fractions and the risk of cardiovascular disease. The guidelines for assessment and treatment of dyslipidemia from the National Cholesterol Education Program are outlined, and cholesterol targets and goals of therapy are discussed. The mechanism of action, place in therapy (eg, first-line, second-line, or add-on), and common side effects are also discussed for each of the available classes of drugs used in the treatment of dyslipidemia.

Entities:  

Year:  2008        PMID: 25126264      PMCID: PMC4106545     

Source DB:  PubMed          Journal:  Am Health Drug Benefits        ISSN: 1942-2962


  23 in total

1.  An overview of cardiovascular disease burden in the United States.

Authors:  George A Mensah; David W Brown
Journal:  Health Aff (Millwood)       Date:  2007 Jan-Feb       Impact factor: 6.301

Review 2.  Micronized fenofibrate: a new fibric acid hypolipidemic agent.

Authors:  D R Guay
Journal:  Ann Pharmacother       Date:  1999-10       Impact factor: 3.154

3.  The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1).

Authors:  Margarita Garcia-Calvo; JeanMarie Lisnock; Herbert G Bull; Brian E Hawes; Duane A Burnett; Matthew P Braun; James H Crona; Harry R Davis; Dennis C Dean; Patricia A Detmers; Michael P Graziano; Meredith Hughes; D Euan Macintyre; Anthony Ogawa; Kim A O'neill; Sai Prasad N Iyer; Diane E Shevell; Marsha M Smith; Yui S Tang; Amanda M Makarewicz; Feroze Ujjainwalla; Scott W Altmann; Kevin T Chapman; Nancy A Thornberry
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-31       Impact factor: 11.205

4.  Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B.

Authors:  G Brown; J J Albers; L D Fisher; S M Schaefer; J T Lin; C Kaplan; X Q Zhao; B D Bisson; V F Fitzpatrick; H T Dodge
Journal:  N Engl J Med       Date:  1990-11-08       Impact factor: 91.245

5.  Benefits of niacin by glycemic status in patients with healed myocardial infarction (from the Coronary Drug Project).

Authors:  Paul L Canner; Curt D Furberg; Michael L Terrin; Mark E McGovern
Journal:  Am J Cardiol       Date:  2005-01-15       Impact factor: 2.778

6.  Effects of torcetrapib in patients at high risk for coronary events.

Authors:  Philip J Barter; Mark Caulfield; Mats Eriksson; Scott M Grundy; John J P Kastelein; Michel Komajda; Jose Lopez-Sendon; Lori Mosca; Jean-Claude Tardif; David D Waters; Charles L Shear; James H Revkin; Kevin A Buhr; Marian R Fisher; Alan R Tall; Bryan Brewer
Journal:  N Engl J Med       Date:  2007-11-05       Impact factor: 91.245

7.  Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis.

Authors:  Anne B Rossebø; Terje R Pedersen; Kurt Boman; Philippe Brudi; John B Chambers; Kenneth Egstrup; Eva Gerdts; Christa Gohlke-Bärwolf; Ingar Holme; Y Antero Kesäniemi; William Malbecq; Christoph A Nienaber; Simon Ray; Terje Skjaerpe; Kristian Wachtell; Ronnie Willenheimer
Journal:  N Engl J Med       Date:  2008-09-02       Impact factor: 91.245

8.  Analyses of cancer data from three ezetimibe trials.

Authors:  Richard Peto; Jonathan Emberson; Martin Landray; Colin Baigent; Rory Collins; Robert Clare; Robert Califf
Journal:  N Engl J Med       Date:  2008-09-02       Impact factor: 91.245

Review 9.  Lipid screening and cardiovascular health in childhood.

Authors:  Stephen R Daniels; Frank R Greer
Journal:  Pediatrics       Date:  2008-07       Impact factor: 7.124

10.  Estrogen plus progestin and the risk of coronary heart disease.

Authors:  JoAnn E Manson; Judith Hsia; Karen C Johnson; Jacques E Rossouw; Annlouise R Assaf; Norman L Lasser; Maurizio Trevisan; Henry R Black; Susan R Heckbert; Robert Detrano; Ora L Strickland; Nathan D Wong; John R Crouse; Evan Stein; Mary Cushman
Journal:  N Engl J Med       Date:  2003-08-07       Impact factor: 91.245

View more
  7 in total

1.  Walnuts change lipoprotein composition suppressing TNFα-stimulated cytokine production by diabetic adipocyte.

Authors:  Kamil Borkowski; Sun J Yim; Roberta R Holt; Robert M Hackman; Carl L Keen; John W Newman; Gregory C Shearer
Journal:  J Nutr Biochem       Date:  2019-03-28       Impact factor: 6.048

Review 2.  Correlates of Blood Pressure Awareness, Treatment, and Control Among Adults 50 Years or Older by HIV Status in Northwestern Tanzania.

Authors:  Charles Muiruri; Bahati Wajanga; Christine Kim; Brandon A Knettel; Carl J Mhina; John A Bartlett; Jamal J Msangi; Msabah A Msabah; Helene Vilme; Samuel Kalluvya
Journal:  Curr Hypertens Rep       Date:  2022-04-06       Impact factor: 4.592

3.  Preformulation Studies of Ezetimibe-Simvastatin Solid Dispersions in the Development of Fixed-Dose Combinations.

Authors:  Agata Górniak; Adrianna Złocińska; Mateusz Trojan; Adrianna Pęcak; Bożena Karolewicz
Journal:  Pharmaceutics       Date:  2022-04-22       Impact factor: 6.525

4.  Effect of atorvastatin on testosterone levels.

Authors:  Muhammad Ismail Shawish; Bahador Bagheri; Vijaya M Musini; Stephen P Adams; James M Wright
Journal:  Cochrane Database Syst Rev       Date:  2021-01-22

5.  Appropriate LDL-C-to-HDL-C Ratio Cutoffs for Categorization of Cardiovascular Disease Risk Factors among Uygur Adults in Xinjiang, China.

Authors:  Qing-Jie Chen; Hong-Mei Lai; Bang-Dang Chen; Xiao-Mei Li; Hui Zhai; Chun-Hui He; Shuo Pan; Jun-Yi Luo; Jing Gao; Fen Liu; Yi-Tong Ma; Yi-Ning Yang
Journal:  Int J Environ Res Public Health       Date:  2016-02-19       Impact factor: 3.390

6.  The effects of statins on hyperandrogenism in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Jianguo Chen; Chaoran Huang; Tongtong Zhang; Wuqing Gong; Xiaofeng Deng; Hua Liu; Jinbo Liu; Yuanbiao Guo
Journal:  Reprod Biol Endocrinol       Date:  2021-12-20       Impact factor: 4.982

7.  The effects of cholesterol accumulation on Achilles tendon biomechanics: A cross-sectional study.

Authors:  Kipling Squier; Alexander Scott; Michael A Hunt; Liam R Brunham; David R Wilson; Hazel Screen; Charlie M Waugh
Journal:  PLoS One       Date:  2021-09-16       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.